CSWYF'
s Net Margin % Range Over the Past 10 Years
Min: 11.11 Med: 20.58 Max: 30.3
Current: 30.26
CSWYF's Net Margin % is ranked better than 94.87% of 956
companies
in the Drug Manufacturers industry
Industry Median: 5.56
vs CSWYF: 30.26
China Shineway Pharmaceutical Group (OTCPK:CSWYF) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
China Shineway Pharmaceutical Group Net Margin % Related Terms
China Shineway Pharmaceutical Group Net Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Shineway Pharmaceutical Group Net Margin % Chart
For the Drug Manufacturers - Specialty & Generic subindustry, China Shineway Pharmaceutical Group's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Shineway Pharmaceutical Group Net Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, China Shineway Pharmaceutical Group's Net Margin % distribution charts can be found below:
* The bar in red indicates where China Shineway Pharmaceutical Group's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Shineway Pharmaceutical Group (CSWYF) has a Net Margin % of 22.61% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on China Shineway Pharmaceutical Group and its competitors. This is 10% above median its historical median of 20.58. Over the past decade, China Shineway Pharmaceutical Group's Net Margin % has ranged from 11.11 to 30.30. According to the industry distribution chart, China Shineway Pharmaceutical Group ranks #49 out of 956 companies in the Drug Manufacturers industry, placing it in the top 5.1%.
Is China Shineway Pharmaceutical Group's Net Margin % too high?
China Shineway Pharmaceutical Group's current Net Margin % of 22.61% is 10% above median its 10-year median of 20.58. Over the past 10 years, this metric has ranged from a low of 11.11 to a high of 30.30. The Drug Manufacturers industry median Net Margin % is 5.56. China Shineway Pharmaceutical Group's value of 22.61% is 306.7% above this industry median. Based on the distribution chart, China Shineway Pharmaceutical Group ranks #49 out of 956 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, China Shineway Pharmaceutical Group has a GF Score™ of 92/100, reflecting its overall financial health beyond just this single metric.
How does China Shineway Pharmaceutical Group's Net Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, China Shineway Pharmaceutical Group ranks #49 out of 956 companies for Net Margin %. This places China Shineway Pharmaceutical Group in the top 5% of its industry — outperforming the majority of peers. The industry median Net Margin % is 5.56. China Shineway Pharmaceutical Group's value of 22.61% is 306.7% above this benchmark. Historically, China Shineway Pharmaceutical Group's own Net Margin % has ranged from 11.11 to 30.30 over the past decade. While the company's 10-year median is 20.58 vs. the industry median of 5.56, China Shineway Pharmaceutical Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Drug Manufacturers company?
The median Net Margin % among Drug Manufacturers companies is 5.56, based on 956 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. China Shineway Pharmaceutical Group's current Net Margin % of 22.61% is 306.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on China Shineway Pharmaceutical Group and its competitors. For the Drug Manufacturers industry, the median Net Margin % is 5.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China Shineway Pharmaceutical Group's current Net Margin % is 22.61%, which is 10% above median its own 10-year median of 20.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Shineway Pharmaceutical Group stock overvalued right now?
China Shineway Pharmaceutical Group (CSWYF) has a current Net Margin % of 22.61%. The stock's GF Value™ is $0.88, compared to a current price of $1.00 — trading 14.1% above its estimated fair value. The current Net Margin % is 22.61%, which is 10% above median its 10-year median of 20.58 and 306.7% above the Drug Manufacturers industry median of 5.56. China Shineway Pharmaceutical Group's overall GF Score™ is 92/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For China Shineway Pharmaceutical Group (CSWYF), the current Net Margin % is 22.61% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is China Shineway Pharmaceutical Group (CSWYF) Overvalued in 2026?
Based on GuruFocus' analysis, China Shineway Pharmaceutical Group stock appears to be overvalued.
The current stock price of $1.00 is trading 14.1% above its estimated GF Value™ of $0.88.
Key valuation signals for CSWYF:
Net Margin %: 22.61% (10% above median its 10-year median of 20.58)
GF Value™: $0.88 vs. price of $1.00 (14.1% above fair value)
Industry Position: 306.7% above the Drug Manufacturers median (#49 of 956)
No single metric tells the full story. See the CSWYF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
China Shineway Pharmaceutical Group Business Description
China Shineway Pharmaceutical Group Ltd is an investment holding company. Along with its subsidiaries, it is engaged in the research, development, manufacturing, and trading of modern Chinese medicines. The company's products comprise injection, soft capsule, granule, traditional Chinese medicine formula granules, and others, of which injections generate maximum revenue for the company. Geographically, the group operates in the People's Republic of China (PRC) and Hong Kong.
92GF Score
Get the complete analysis for CSWYF
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CSWYF has been successfully added to your 
